Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06468163

Efficacy of Local Antibiotic Injection Via a Catheter for Treating Acute Periprosthetic Infections After Knee DAIR Surgery

Prosthetic Joint Infection (PJI) is a severe complication following joint replacement surgery, imposing significant economic and health burdens on patients. For acute PJI, the DAIR (Debridement, Antibiotics, and Implant Retention) procedure is a necessary and effective treatment method, as it effectively clears the infection while preserving the prosthesis, thereby avoiding more complex surgical interventions. However, the practice of using drainage tubes postoperatively is controversial. Some studies suggest that drainage tubes may increase the risk of infection, while other literature indicates no statistically significant difference in infection risk associated with their use.In this context, Professor Li Cao's team at Xinjiang Medical University has improved the traditional DAIR procedure by incorporating long-term local antibiotic injections post-surgery, achieving positive results. Despite this, the specific method of antibiotic injection, particularly whether to use a drug infusion tube, remains under debate. The use of an infusion tube can reduce patient discomfort, shorten the local disinfection process, and theoretically decrease the time the incision is exposed to the external environment, potentially lowering the infection risk. However, the validity of these theoretical assumptions needs further confirmation through high-level scientific research. This study aims to evaluate whether there are differences in joint function recovery, changes in blood infection markers, and the incidence of postoperative complications between using and not using an infusion tube for local antibiotic injection after knee DAIR surgery. To assess the value of the infusion tube in local antibiotic injection post-knee DAIR surgery, a randomized controlled trial (RCT) will be conducted. Eligible patients will be randomly assigned to the infusion tube group (experimental group) or the non-infusion tube group (control group). The study will prospectively collect basic information, joint function scores, blood infection markers, and postoperative complication data from both groups, including patient age, gender, educational background, and postoperative blood test results. Ultimately, the RCT aims to demonstrate the therapeutic efficacy of the infusion tube method.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years old, gender is not limited;
  • Meet the diagnostic criteria for DAIR surgery of artificial knee joint;
  • Receiving knee DAIR surgery;
  • Voluntary and signed informed consent.

Exclusion criteria

  • Patients with chronic PJI infection undergoing total knee revision;
  • Patients with severe knee joint infection who cannot undergo artificial joint replacement;
  • Progressive renal insufficiency (stage 4 and above) or glomerular filtration rate less than 30ml/min;
  • periprosthesis infection after multiple joint replacement;
  • Active infection at the site of intravenous or joint injection;
  • long-term use of anticoagulants or antiplatelet drugs due to other diseases;
  • Have sepsis or positive blood culture within the last 30 days;
  • Radiotherapy and chemotherapy are required due to neoplastic diseases;
  • Receiving systemic glucocorticoid therapy (prednisone > 10mg/ day or equivalent hormone medication);
  • severe immunodeficiency diseases (such as stage 3 HIV, sickle cell anemia, splenectomy, etc.);
  • Have a history of drug abuse;
  • Treatment of bone marrow or other transplants with immunosuppressive drugs;
  • Pregnant, parturient and lactating women;
  • Participating in other clinical trials;
  • Researchers believe that other reasons are not appropriate for clinical trial participants.

Treatment and study plan

Drug infusion into joint through catheter.

Device

With or without using catheter after DAIR operation for drug infusion.

Primary outcomes

  1. Infection control rate

    Time frame: Two year after surgery

    Infection control rate

  2. Time between infection recurrence

    Time frame: Two year after surgery

    Time between infection recurrence

  3. Re-operation rate

    Time frame: Two year after surgery

    Re-operation rate

Secondary outcomes

  1. X-ray

    Time frame: One day before surgery and two years after surgery

    X-ray

  2. American Knee Society Score (AKS score)

    Time frame: One day before surgery and two years after surgery

    American Knee Society Score is used to evaluate the outcomes of knee replacement surgery. This scoring system consists of two main components: the knee score and the function score.

    Knee Score: This primarily assesses the condition of the knee joint itself, including pain, stability, and range of motion. The higher of the score, the better of the functional result.

  3. Redness, Edema, Ecchymosis, Discharge, and Approximation score (REEDA score)

    Time frame: One day before surgery, three month after surgery

    The REEDA score is a clinical tool used to assess the healing of perineal wounds and other skin wounds, particularly after childbirth. REEDA stands for Redness, Edema, Ecchymosis, Discharge, and Approximation. Each of these five parameters is scored on a scale from 0 to 3, with higher scores indicating more severe symptoms. The total REEDA score can range from 0 to 15.

  4. Visual Analog Scale score

    Time frame: One day before surgery and two years after surgery

    The VAS score, or Visual Analog Scale, is a tool commonly used to measure a person's level of pain. The VAS is a simple, subjective measure that consists of a straight line, typically 10 centimeters long, anchored by two endpoints. One end of the line represents "no pain" and the other end represents "worst pain imaginable." For example, if the VAS line is 10 cm long and the patient's mark is at 7 cm from the "no pain" end, their pain score would be 7 out of 10.

  5. White blood cell count

    Time frame: One day before surgery and one day after surgery

    White blood cell count from blood

  6. Erythrocyte sedimentation rate (ESR)

    Time frame: One day before surgery and one day after surgery

    It measures the rate at which red blood cells settle to the bottom of a test tube within one hour.

    Normal ranges:

    Male: 0 to 15 millimeters per hour (mm/hr) Female: 0 to 20 millimeters per hour (mm/hr)

  7. C-reactive protein (CRP)

    Time frame: One day before surgery and one day after surgery

    C-reactive protein (CRP) is a protein produced by the liver that significantly increases in response to inflammation or infection. Normal range for CRP is less than 10 milligrams per liter (mg/L).

  8. Synovial fluid white blood count

    Time frame: One day before surgery and one day after surgery

    Synovial fluid white blood count

  9. Polymorphonuclear neutrophil percentage in synovial fluid (SF-PMN)

    Time frame: One day before surgery and one day after surgery

    Polymorphonuclear neutrophil percentage in synovial fluid refers to the proportion or percentage of polymorphonuclear neutrophils (PMN) present in the synovial fluid. This measurement is important in the assessment of joint health and inflammation, particularly in conditions such as arthritis and infections affecting the joints. Normal range: Less than 80%.

  10. Alanine Aminotransferase (ALT)

    Time frame: One day before surgery and one day after surgery

    An enzyme found in the liver that helps convert proteins into energy. Elevated levels indicate liver damage. Normal range: 10 to 40 units per liter (U/L)

  11. Aspartate Aminotransferase (AST)

    Time frame: One day before surgery and one day after surgery

    An enzyme found in the liver and other tissues. High levels can indicate liver damage but are less specific than ALT. Normal range: 10 to 40 units per liter (U/L)

  12. Serum Creatinine

    Time frame: One day before surgery and one day after surgery

    Measures the level of creatinine in the blood. Elevated levels can indicate impaired kidney function. Normal range: 62 to 115 micromoles per liter (µmol/L).

  13. Blood Urea Nitrogen (BUN)

    Time frame: One day before surgery and one day after surgery

    Measures the amount of nitrogen in the blood that comes from urea. Elevated BUN levels can indicate impaired kidney function. Normal range: 2.5 to 7.1 millimoles per liter (mmol/L).

Study contacts

Contact information is provided by the study sponsor or research team.

Li Cao, M.D.

CONTACT

[email protected]

+8613909915960

Long Hua, M.D.

CONTACT

[email protected]

+8615099182364

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital of Xinjiang Medical University

Other

Registry information

Official study title

Efficacy of Local Antibiotic Injection Via a Catheter for Treating Acute Periprosthetic Infections After Knee DAIR Surgery: A Prospective, Randomized Controlled Trial Study

Acronym: YES

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jun 21, 2024
Registry last updated
Jun 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.